Popular Articles
Grapefruit Benefits

New Lab Test Helps Predict Kidney Damage
Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study in the Journal of the American Society of Nephrology (JASN). "As a stand-alone marker, urine NGAL performed moderately well in predicting ongoing and subsequent AKI," comments T. Alp Ikizler, MD (Vanderbilt University).
generic viagra online
IGF Oncology Announces Targeted Cancer Drug Results
IGF Oncology, a St. Paul-based company, reported the publication of results of a study of its new targeted anti-cancer drug in a peer-reviewed scientific journal. The company"s drug is a modified version of a commonly used cancer chemotherapy drug, modified to be targeted much more specifically to cancer cells and to bypass healthy cells. The results in mice, which are reported in the June issue of Translational Research, show the drug is significantly more effective than the standard drug, methotrexate, even at 6-fold lower dose. The lower dose is expected to result in lower side effects. The study was carried out in collaboration with the University of Minnesota. The authors include Hugh McTavish, the founder of IGF Oncology, and Arkadiusz Dudek, Oncologist and Assoc. Professor of Medicine at the University of Minnesota.
News of the day
International Groups Express Concern About Cambodian 'AIDS Colony'
In an open letter to Cambodia"s prime minister and health minister, more than 100 international HIV/AIDS advocates and human rights organizations "accused the Cambodian government of herding HIV-affected families into an "AIDS colony" outside the capital, Phnom Penh," the Guardian reports (McCurry, 7/28).
Nutrition

'Chronic Underfunding' Could Hinder Progress In HIV Treatment, Opinion Piece Says

Recent cuts to Arizona"s AIDS Drug Assistance Program and other state services due to "chronic underfunding of HIV services at the state and federal level, the increasing cost of medications and the increasing number of persons living with HIV who lack insurance to pay for these life-saving drugs," will likely reverse the progress made in HIV treatment, J. Kevin Carmichael, an associate medical director at El Rio Community Health Center in Tucson, Ariz., writes in an Arizona Daily Star opinion piece. He continues, "Our legislators need to hear our voices and understand that we cannot accept a shortsighted approach to a fiscal crisis that builds in years of HIV-related illness and guarantees significant future costs" (Carmichael, Arizona Daily Star, 6/15). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):